Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its wide range of generic and branded pharmaceuticals, has been facing difficulties in recent months. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A final decis